Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.

Ann Intensive Care · 2011 · PMC3224484 · PMID 21906344

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The first clinical trials showed a trend toward reduced DCI and improved outcome [ 69 ].

also in 53,322 other papers

did not reach statistical significanceno p-value reported

The randomized, double-blind, placebo-controlled MASH (Magnesium in Aneurysmal Subarachnoid Hemorrhage) study, including 283 patients revealed reduced DCI and improved outcome at 3 months, but the differences with placebo did not reach statistical significance [ 70 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.